Agenovir Patents – Insights & Stats (Updated 2023)

Agenovir has a total of 71 patents globally, out of which 1 has been granted. Of these 71 patents, more than 5% patents are active. United States of America is where Agenovir has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Agenovir.

Agenovir was founded in the year 2014. The Company operates as a pharmaceutical company. The Company researches and develops a novel class of nuclease-based anti-viral therapeutics for diseases associated with viral reservoirs.

Do read about some of the most popular patents of Agenovir which have been covered by us in this article and also you can find Agenovir patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Agenovir patent portfolio.

How many patents does Agenovir have?

Agenovir has a total of 71 patents globally. These patents belong to 19 unique patent families. Out of 71 patents, 4 patents are active.

How Many Patents did Agenovir File Every Year?

Agenovir Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAgenovir Applications FiledAgenovir Patents Granted
20201
20192
201881
201712
201648

How many Agenovir patents are Alive/Dead?

Agenovir Patent Portfolio

 How Many Patents did Agenovir File in Different Countries?

Agenovir Worldwide Patent Filing

Countries in which Agenovir Filed Patents

CountryPatents
United States Of America17
Europe9
Canada8
Japan7
Hong Kong (S.A.R.)4
China3
Australia3
United Kingdom2

Where are Research Centres of Agenovir Patents Located?

R&D Centers of Agenovir

10 Best Agenovir Patents

US20160350476A1 is the most popular patent in the Agenovir portfolio. It has received 44 citations so far from companies like Biomedrex Ab, Synthego Corporation and The Broad Institute, Inc.

Below is the list of 10 most cited patents of Agenovir:

Publication NumberCitation Count
US20160350476A144
US20160346360A141
WO2017147446A141
WO2016196282A140
US20160348074A139
US20160346362A139
WO2017147432A139
WO2016196273A139
US20170087225A138
WO2016161260A138

What Percentage of Agenovir US Patent Applications were Granted?

Agenovir (Excluding its subsidiaries) has filed 17 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 5.88%.

Below are the key stats of Agenovir patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Agenovir?

Law FirmTotal ApplicationsSuccess Rate
Seed Ip Law Group175.88%

What are Agenovir key innovation segments?

What Technologies are Covered by Agenovir?

The chart below distributes patents filed by Agenovir in different countries on the basis of the technology protected in patents. It also represents the markets where Agenovir thinks it’s important to protect particular technology inventions.

R&D Focus: How has Agenovir search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Agenovir?

Related Articles

Celcem Patents – Insights & Stats (Updated 2024)

Celcem has a total of 28 patents globally, out of which all patents have been granted. Of these 28 patents, all patents patents are active. Singapore is where Celcem has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.